<DOC>
	<DOCNO>NCT01351870</DOCNO>
	<brief_summary>This international prospective randomise trial , compare two radiotherapy regimen child adolescent ( age 4 5 year 21 year inclusive ) carefully stag 'standard risk ' medulloblastoma .</brief_summary>
	<brief_title>Hyperfractionated Versus Conventionally Fractionated Radiotherapy Standard Risk Medulloblastoma</brief_title>
	<detailed_description>Patients eligible study non-metastatic medulloblastoma ( image CSF cytology ) diagnosis . Patients randomised standard arm receive conventionally fractionate ( day ) radiotherapy dose 54 Gy posterior fossa 23.4 Gy craniospinal axis . The experimental arm hyperfractionated ( twice day ) radiotherapy ( 1 Gy b.d . ) dose 60 Gy posterior fossa additional 8 Gy tumour bed 36 Gy craniospinal axis . Both group receive identical chemotherapy consist eight weekly dos Vincristine give radiotherapy 8 course CCNU , cisplatin vincristine follow radiotherapy .</detailed_description>
	<mesh_term>Medulloblastoma</mesh_term>
	<criteria>Age diagnosis least 4 year 5 year ( accord policy National Brain Tumour Group ) less 22 year . Histologically proven medulloblastoma , include follow variant ( WHO classification 2000 ) : classic medulloblastoma , nodular / desmoplastic medulloblastoma , melanotic medulloblastoma , medullomyoblastoma No CNS metastasis MRI supratentorial , arachnoid posterior fossa spine . No clinical evidence extraCNS metastasis No tumour cell cytospin lumbar CSF . Central Review CSF cytology recommend mandatory . It leave national policy . Radiotherapy start 40 day surgery . Ability receive twice daily radiotherapy . Vital function within normal range age group . CTC grade &lt; 2 liver , renal , haematological audiological function . No medical contraindication radiotherapy chemotherapy . Written informed consent ( patient assent appropriate ) accord law participate country . Written inform consent also seek biological study . National local ethical committee approval accord law participate country ( include approval biological study ) . One inclusion criterion lack . Brainstem supratentorial primitive neuroectodermal tumour . Atypical teratoid rhabdoid tumour . Medulloepithelioma . Ependymoblastoma . Large cell m√©dulloblastoma . Metastatic medulloblastoma ( CNS MRI and/or positive cytospin postoperative lumbar CSF ) . Patient previously treat brain tumour type malignant disease . Patients pregnant . Females sexually active take reliable contraception . Known predisposition medulloblastoma e.g . Gorlin 's syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>